BANGKOK (Reuters) — Thailand on Saturday started testing a vaccine towards the coronavirus on monkeys after optimistic trials in mice, an official mentioned.
Thailand’s minister of upper training, science, and analysis and innovation, Suvit Maesincee, mentioned researchers had moved testing of the vaccine to monkeys and hoped to have a “clearer consequence” of its effectiveness by September.
“This challenge is for the human race, not simply Thais. The prime minister (Prayuth Chan-ocha) has outlined a coverage that we should develop a vaccine and be a part of the world neighborhood workforce on this,” Suvit advised reporters on Saturday.
Thailand introduced on Wednesday that it was creating a vaccine – one in every of a minimum of 100 potential vaccines within the works worldwide – and hoped to have it into manufacturing by subsequent yr.
Suvit mentioned that Thailand has began reserving two producers for its vaccine for COVID-19, the illness attributable to the novel coronavirus.
Because the new virus emerged in China late final yr, COVID-19 has unfold around the globe, infecting greater than 5 million individuals and killing greater than 300,000.
The Thai vaccine makes use of messenger RNA, which prompts physique cells to supply antigens, molecules on the floor of viruses, that spur the immune system into motion.
The Thai vaccine is being developed by the Nationwide Vaccine Institute, the Division of Medical Science and Chulalongkorn College’s vaccine analysis centr
fbq(‘init’, ‘1076130949081971’); // Insert your pixel ID right here.